clinical aspects of smoking cessation jean-pierre zellweger, md swiss lung association and int....

30
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Upload: susanna-stephens

Post on 28-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Clinical aspects of smoking cessation

Jean-Pierre Zellweger, MD

Swiss Lung Association and

Int. Union against TB and Lung Disease (The Union)

Page 2: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

COPD and smoking

• Smoking is closely related to COPD and one of the main causes of the disease

• Smoking cessation is the only intervention with a proven impact on the mortality

• Smoking cessation is cost-effective

Page 3: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

The natural history of chronic airflow obstruction (Fletcher C, 1977)

Page 4: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Reduction in health risk after smoking cessation

Page 5: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Impact of smoking cessation on the decline in lung functtion (The Lung Health Study, 1994)

Page 6: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Impact of smoking cessation on survival (The Lung Health Study)

Page 7: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Smoking cessation:

• Role of the smoker:– Decision– Change in habits– Overcoming the obstacles– Acceptance of the dependence

• Role of the Health-care professional (MD, nurse)• Role of the social environment and relatives

Page 8: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Efficacy of resident’s training: smoking habits of the patients after 1 year

trained control

Page 9: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence,

US DHHS 2008 update

Page 10: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the principles (US DHHS 2008 update)

• Tobacco dependence is a chronic condition• Effective treatment exist• Health care providers should identify, document and offer

treatment to every tobacco user• Clinicians should encourage smokers to make a quit attempt• Brief tobacco dependence treatment is effective• Problem solving and social support are both important parts of

the intervention • The effectiveness of counseling is increased by medication• Interventions for smoking cessation are highly cost-effective

Page 11: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, US DHHS 2008 update

Page 12: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy: five « A »

Page 13: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy: five « A »

Page 14: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy: five « A »

Page 15: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy: five « A »

Page 16: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy: five « A »

Page 17: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy: addressing the obstacles

Page 18: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy : addressing the obstacles

tobacco

depression

COPD

Page 19: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy : addressing the obstacles

Page 20: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy : addressing the obstacles

Page 21: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence, the strategy : addressing the obstacles

Page 22: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence: medication

• Nicotine Replacement Therapy (NRT)– Gum, Inhaler, Lozenge, Nasal spray, Patch

• Bupropion• Varenicline• All with proven efficacy (increase the success rate by a

factor 2 to 3)• Can be combined with other interventions• All attenuate the withdrawal symptoms• Not available or very expensive in many countries

Page 23: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Treating tobacco use and dependence: medication

• Nicotine Replacement Therapy (NRT)– Replace nicotine needed by central nervous system– Nicotine alone does not induce cancer, COPD, cardio-vascular

disease but promotes dependence (which is already present in most long- term smokers!)

• Bupropion– Effective but some side effects– Can be combined with NRT

• Varenicline– Effective but some side effects– Cannot be combined with NRT

Page 24: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

The position of the Int Union against TB and Lung Diseases (The Union)

• The Union runs programmes on respiratory diseases with public health impact: TB (historical), COPD, asthma

• Smoking (and passive smoking) has a major impact on lung health in developing countries and increases the risk of tuberculosis

• COPD and tuberculosis are linked together• Both affect growingly developing countries• Specific intervention for smokers with tuberculosis have

been developed• Smoking intervention improves the cure rate of tuberculosis

Page 25: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Page 26: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

The position of the Union

• Smoking cessation intervention based on brief advice is feasible in developing countries

• Brief advice is given to patients under treatment for tuberculosis

• The advice is repeated at regular intervals to patients unwilling to quit

• The intervention is integrated in a pilot project « Comprehensive Approach to Lung Health » in Benin, China and Soudan and will be extended to further countries

• The intervention benefits tuberculosis patients and other patients (effect of training the Health Care providers)

Page 27: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Impact of training the HCW and enrolling patients in smoking cessation program on the

outcome of TB

0

10

20

30

40

50

60

7080

90

cure default smokingcessation

enrolled

not enrolled

El Sony A, Int J Tuberc Lung Dis 2007;11(2):150-5

Page 28: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

GLOBAL MANDATE FOR COPD CARE AND COPD PATIENTS’ BILL OF RIGHTS

The right to receive early and accurate diagnosis The right for information and education about COPD The right for support and understanding The right to receive care and treatment that will benefit them The right to their fair share of society’s involvement and

investment in their welfare and care The right to advocate with other COPD patients and

supporters for improved COPD care and COPD prevention The right to safe air and environment

Page 29: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)

Smoking cession and COPD:the take-home messages

• Smoking cessation is the most important intervention/action for improving the outcome of COPD

• Smoking counseling is cost-effective, even (and particularly) the minimal intervention by all Health-Care Workers and related professionals

• Smoking counseling may be frustrating on individual level but is rewarding at society level

• Patients willing to stop smoking should approach their physician/HCW

• Physicians and HCW have to be trained in smoking counseling

Page 30: Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)